Brandywine Oak Private Wealth’s GSK GSK Stock Holding History

Brandywine Oak Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,333	Closed	-$290K	–	306
2022 Q2	$290K	Buy	5,333 +2	+0%	+$110	0.04%	252
2022 Q1	$290K	Buy	5,331 +1	+0%	+$54	0.03%	263
2021 Q4	$293K	Buy	5,330 +480	+10%	+$25K	0.03%	253
2021 Q3	$231K	Buy	+4,850	New	+$244K	0.03%	306
2020 Q4	–	Sell	-5,134	Closed	-$241K	–	271
2020 Q3	$241K	Hold	5,134	–	–	0.04%	222
2020 Q2	$261K	Buy	5,134 +1	+0%	+$51	0.05%	189
2020 Q1	$243K	Buy	5,133 +105	+2%	+$5.6K	0.05%	190
2019 Q4	$295K	Buy	5,028 +314	+7%	+$17.5K	0.05%	181
2019 Q3	$251K	Buy	+4,714	New	+$243K	0.05%	196
2019 Q1	–	Sell	-716	Closed	-$34K	–	375
2018 Q4	$34K	Buy	+716	New	+$35.3K	0.01%	404

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Brandywine Oak Private Wealth's GSK Position: Q3 2022 in Review

Brandywine Oak Private Wealth sold out of GSK (GSK) in Q3 2022, closing a stake of 5,333 shares — an estimated $290K sold.

Brandywine Oak Private Wealth first reported a position in GSK in Q4 2018 and held it in 10 quarters. The position peaked at $295K in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Brandywine Oak Private Wealth reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Brandywine Oak Private Wealth sold 5,333 GSK shares in Q3 2022, an estimated $290K.
Brandywine Oak Private Wealth first reported a position in GSK in Q4 2018 and held it in 10 quarters.
Brandywine Oak Private Wealth's GSK position peaked at $295K in Q4 2019.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Brandywine Oak Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.